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Abstract We have searched for post-translational modifications 
in tubulin of the diplomonad Giardia lamblia, which is a 
representative of the earliest branches in eukaryotic evolution. 
The carboxyterminal peptide of a-tubulin was isolated and 
characterized by automated sequencing and mass spectrometry. 
Some 60% of the peptide is unmodified, while the remainder 
shows various degrees of polyglycylation. The number of glycyl 
residues in the lateral side chain ranges from 2 to 23. All peptide 
species encountered end with alanine-tyrosine, indicating the 
absence of a detyrosination/tyrosination cycle. We conclude that 
tubulin-specific polyglycylation could be as old as tubulin and 
axonemal structures. 
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to search for their evolutionary origin because they are unique 
to tubulin, a typical eukaryotic protein. 
Based on ultrastructural characteristics and several molecu- 
lar phylogenies there is general agreement that the diplomo- 
nads were among the first branches which emerged from the 
eukaryotic tree. Diplomonads, like other Archezoa, are 
thought o have arisen before the acquisition of mitochondria 
and to have retained many primitive features of the first nu- 
cleated cells [17-21]. Giardia lamblia is a particularly well- 
characterized iplomonad. Its cytoskeleton is dominated by 
microtubules. Giardia has eight flagellar axonemes and a large 
disc cytoskeleton which consists of rnicrotubules and the mi- 
croribbons, which arise from ~-giardin [22,23]. Here we report 
an analysis of the post-translational modifications of ct-tubu- 
lin from Giardia based on the characterization f its carboxy- 
terminal peptide. 
1. Introduction 2. Materials and methods 
The c~l]-tubulin heterodimer, the structural unit of micro- 
tubules, is the target of various post-translational modifica- 
tions. Some of these, like the acetylation of lysine-40 in certain 
~-tubulins [1,2] and some phosphorylation sites in the carboxy- 
terminal region [3,4] are more general post-translational 
modifications, while others seem unique to tubulins. Thus 
the carboxyterminal tyrosine of certain ct-tubulins is subject 
to a detyrosination/tyrosination cycle based on a carboxypep- 
tidase and the well-characterized tubulin-tyrosine ligase [5,6]. 
After loss of the tyrosine and penultimate glutamic acid resi- 
due the resulting tubulin is no longer a substrate for tubulin- 
tyrosine ligase [7-9]. Two other unique post-translational 
modifications involve the presence of a polyglutamyl- or 
polyglycyl side chain attached via an isopeptide bond to a 
particular glutamic acid residue in the carboxyterminal region 
of ct- and 13-tubulin. The exact position of this modified res- 
idue has been identified in all brain tubulins [3,8,10-13]. The 
more recently discovered polyglycylation has been document- 
ed for ct- and 13-tubulin from the ciliary axonemal microtu- 
bules of the protist Paramecium [14] and from the sperm ax- 
onemal microtubules of mammals [15] (Plessmann, U. and 
Weber, K. unpublished results) and sea urchins [16]. Thus 
all post-translational modifications unique to tubulin involve 
the negatively charged carboxyterminal 10 to 15 residues 
[12,15]. Since the molecular functions of these post-transla- 
tional modifications are still a matter of debate it is interesting 
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2.1. Cells, cytoskeletal preparations and tubulin isolation 
The origin of the Giardia lamblia isolate WB has been described 
[24]. Trophozoites were cultivated in TY-S-33 medium with antibiotics 
[25]. Several cultures of Giardia l. were harvested, washed in phos- 
phate-buffered saline and frozen as pellets in liquid nitrogen. Frozen 
pellets (total 1.5 x 109 cells) were suspended in 50 ml of Tris-HC1, pH 
8.3, 2 mM EDTA, 2 mM DTT, 0.5 mM ATP, 2 mM MgSO4, 150 
mM KCI containing 0.5% Triton X-100. Detergent extraction of cy- 
toskeletons was as described [26]. Cytoskeletons were resuspended in 
SDS sample buffer, boiled and subjected to SDS-PAGE using a prep- 
arative 10% gel. After staining with Coomassie brilliant blue the ma- 
jor band corresponding to et- and [~-tubulin was excised, washed with 
water and frozen at -70°C until use. 
2.2. Isolation and characterization of the carboxyterminal peptides of 
~-tubulin 
Tubulin present in dye-stained gel pieces was electrophoretically 
concentrated into a small band by the agarose gel concentration sys- 
tem [27]. Treatment with endoproteinase LysC (Boehringer, Man- 
nheim, Germany) was at 3 gg/ml in 0.1 M Tris-HC1, pH 8.5, 5% in 
acetonitrile, for 16 h at 37°C. The digest was recovered in buffer A (20 
mM sodium phosphate, pH 7) by the use of a SMART (Pharmacia, 
Uppsala, Sweden) fast desalting column and separated on a Mono Q 
column (1.6 x 50 mm) equilibrated with buffer A with a 2.4 ml salt 
gradient (0-0.5 M NaC1 in buffer A) followed by a 0.9 M salt wash. 
The flow rate was 100 lal/min. The elution profile was monitored by 
absorption at 214 nm and conductance measurement. Fractions of 
100 gl were collected. Appropriate peak fractions were processed by 
reverse-phase HPLC on a Vydac 218 TP51 column. Peptides were 
eluted with a 2.4 ml linear gradient from 10 to 80% solvent B at a 
flow rate of 40/al/min. Solvent A was 0.1% TFA. Solvent B was 70% 
acetonitrile in0.08% TFA. Elution profiles were monitored by absorp- 
tion at 214 nm. Peak fractions were collected manually and character- 
ized by mass spectra recorded with a KRATOS MALDI 3 time of 
flight mass spectrometer (Shimadzu, Duisburg, Germany). The matrix 
was ct-cyano-4-hydroxy-cinnamic cid in 30% acetonitrile, 0.06% 
TFA. Spectra of negative ions were recorded in the linear mode. 
Calibration was with bovine insulin, a-melanocyte stimulating hor- 
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Fig. 1. SDS-PAGE analysis of Giardia cytoskeletal preparation. 
Giardia cells were extracted with 0.5% Triton X-100 and the insolu- 
ble residue was subjected to SDS-PAGE using a 10% gel. Note the 
strong tubulin band marked by a star and the lower molecular 
weight giardins. 
mone and synthetic peptides. Automated Edman degradation used 
instruments with online phenylthiohydantoin amino acid analysis. 
3. Results 
Giardia cells were extracted with a buffer containing Triton 
X-100 (see Section 2). SDS-PAGE showed that the resulting 
cytoskeletal preparation is dominated by tubulin and the giar- 
dins (Fig. 1; [26]). Preparative SDS-PAGE was used to purify 
Giardia tubulin. The Coomassie brilliant blue-stained band 
was excised and an aliquot of the gel fragments was processed 
for digestion with endoproteinase LysC. The digest was chro- 
matographed on a small Mono Q column and all later emerg- 
ing peaks were subjected to reverse-phase HPLC. All peptide 
containing fractions from the HPLC columns were character- 
ized by mass spectrometry. Major fractions were also ana- 
lyzed by automated Edman degradation. 
The carboxyterminal peptide of Giardia a-tubulin eluted at 
several positions from the Mono Q column. The major 
amount, eluting around fraction 26, provided several peaks 
in subsequent HPLC. Some 50% of the peptide, which eluted 
later from the HPLC column showed a mass of 2652 (Fig. 
2A). This value is in excellent agreement with the sequence 
DYEEIGAETLGDGEGEDMEEDDAY established by auto- 
mated sequencing (calculated value 2652). Around 40% of the 
peptide luting in two additional fractions howed polyglycy- 
lation. In one fraction the number of extra glycyl residues 
ranged from 0 to 6. Components with 0, 2 and 3 extra glycyl 
residues were the major constituents in this fraction (Fig. 2B). 
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Fig. 2. Mass spectra of the carboxyterrninal peptides of Giardia c¢-tubulin generated by endoproteinase LysC. (A) The MALDI mass pectrum 
of the unmodified peptide (marked GO). Its mass/charge of 2652 fits exactly the amino acid sequence established by automated Edman degrada- 
tion (top line in B). The minor peak marked by a star has a mass increment of 16 and corresponds to a fraction of the peptide in which the 
methionine was oxidized to the methionine sulfoxide. (B) Fraction of the peptide containing the unmodified species and several glycylated com- 
ponents which are marked as G2-G6 according to the number of additional glycyl residues. Stars are used as in (A). The sequence of this 
preparation (top line) was the same as established before, except for a lower yield at the position of the second glutamic acid (underlined) fol- 
lowing the methionine (see Section 3). (C) The MALDI spectrum of a highly glycylated peptide, which was recovered in low yield. Note that 
the number of additional glycine residues ranges from 14 to 23 (peaks G14 to G23). Stars are used as above. 
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Fig. 3. Mass spectrum of the penultimate carboxyterminal peptide 
of Giardia ct-tubulin generated by endoproteinase LysC. Its mass/ 
charge of 3354 fits exactly the amino acid sequence established by 
automated Edman degradation (top line). The star indicates a frac- 
tion of the peptide in which the methionine was oxidized to methio- 
nine sulfoxide. 
In the earlier eluting fraction the number of glycyl increments 
ranged from 6 to 16. Sequencing of the former fraction, which 
also contained some unmodified peptide, yielded the same 
sequence as above, but the second glutamic acid residue (un- 
derlined in the sequence) following the unique methionine 
showed a reduced yield compared to the preceeding and fol- 
lowing residue. Thus the oligoglycyl chains may be connected 
to this particular glutamic acid residue via the isopeptide 
bond. 
A more heavily glycylated erivative of the carboxyterminal 
ct-tubulin peptide eluting around fraction 19 from the Mono 
Q column was a minor component. Here the number of extra 
glycyl residues ranged from 14 to 23 and the main component 
showed 17 glycines for the side chain (Fig. 2C). All derivatives 
of the carboxyterminal peptide end with a tyrosine preceeded 
by an alanine (see Section 4). The cDNA sequence of Giardia 
[3-tubulin (accession umber P05304; [28]) predicts that LysC 
digestion should yield a 53 residue carboxyterminal peptide. 
In agreement with earlier work on bull sperm tubulin [15] we 
assume that this peptide is not recovered by our procedures. 
A small amount of peptide material eluting very late from 
the Mono Q column (around fraction 31) gave rise to several 
peaks upon HPLC analysis. Two of these showed in mass 
spectrometry components related by one and two glutamic 
acid residues. Since their mass values seem unrelated to those 
of the ct-tubulin peptides we do not know whether they reflect 
a glutamylated tubulin. Such a possibility can only be ex- 
plored once sufficient material for sequence analysis is avail- 
able. 
Since for diplomonads only a partial ct-tubulin sequence 
(Hexamita inflata) is known [21] we completed the carboxy- 
terminal region by the characterization of the penultimate 
peptide of Giardia which shows no modifications (Fig. 3). 
Its sequence starts at the last lysine in the partial Hexamita 
sequence (accession umber U37080) and covers 29 residues. 
These are identical with the corresponding sequence (residues 
402 to 430) of ~-tubulin from Trypanosoma brucei ([29]; ac- 
cession number P04106). The following carboxyterminal pep- 
tide of Giardia (see above) is by three residues longer than the 
Trypanosoma sequence. 
4. Discussion 
Using sequence analysis and mass spectrometry we have 
shown that a sizeable fraction of the carboxyterminal peptide 
of Giardia ct-tubulin is polyglycylated. The number of glycyl 
residues in the lateral side chain ranges from 2 to 23 with the 
species containing 2 to 6 glycyl residues accounting for the 
majority of the peptide species. Although the Giardia ~-tubu- 
lin was not analyzed, previous experience with axonemal mi- 
crotubules from the ciliate Paramecium and the sperm flagella 
of sea urchin show that both ct- and 13-tubulin are polygly- 
cylated [14,16]. An earlier report for bull sperm [15] documen- 
ted only I]-tubulin glycylation but subsequent work showed 
that the glutamylated t~-tubulin can carry up to 23 glycyl 
residues (Plessmann, U. and Weber, K. unpublished results). 
Given the fact that tubulin polyglycylation has so far emerged 
primarily in axonemal structures (above references and [30]) 
we assume that this will also be the case in Giardia which has 
eight flagellar axonemes. Whether the large disk cytoskeleton 
consisting of microtubules and the giardin microribbons [26] 
also contains glycylated tubulin is currently not known. An 
answer may be expected from the use of recently described 
antibodies pecific for highly glycylated tubulins [30]. 
In spite of the considerable heterogeneity of the carboxy- 
terminal peptide of tx-tubulin due to oligoglycyl chains of 
various length all derivatives end with the sequence D-A-Y, 
which after detyrosination would not be accepted as substrate 
by mammalian tubulin-tyrosine ligase [9]. This result and the 
lack of any detyrosinated tx peptide argue that Giardia tubulin 
is not subject o a detyrosination/tyrosination cycle. Here we 
note that tx-tubulin of Trypanosoma brucei, a member of the 
Kinetoplastida, is, in line with its sequence, subject o such a 
cycle [31,32] while tx-tubulins from some ciliates show se- 
quences not compatible with the normal cycle (see for instance 
[14]). The reason for this interesting variability is not known. 
Although a polyglutamylated ct-tubulin peptide of Giardia 
was not encountered we cannot exclude the possibility that 
this post-translational modification exists at low abundancy 
and possibly involves another tubulin isotype (see Section 
3). Since cytoskeletal preparations were performed on pre- 
viously frozen cells, normal cytoplasmic microtubules may 
not have been recovered in the insoluble residue used for 
tubulin purification. In addition some modified tubulins can 
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show abnormal mobility and poor staining in SDS-PAGE 
[30]. Thus future experiments on Giardia should make use 
of antibodies pecific for some polyglutamylated tubulins [33]. 
The combined results show that at least one post-transla- 
tional modification unique to tubulin is already present in the 
diplomonad Giardia, which belongs to the earliest branches in 
eukaryotic evolution. Polyglycylation seems connected to ax- 
onemal organization (see above) and Giardia has already ty- 
pical axonemes. Polyglycylation is thought o occur after ax- 
onemes are formed and may be involved in membrane 
connections [34] and a structural distinction between A and 
B tubules of the outer doublet microtubules [16]. 
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